TY - JOUR AU - Theofilopoulos, A. N. AU - Lawson, B. R. PY - 1999 DA - 1999// TI - Tumour necrosis factor and other cytokines in murine lupus JO - Ann Rheum Dis VL - 58 UR - https://doi.org/10.1136/ard.58.2008.i49 DO - 10.1136/ard.58.2008.i49 ID - Theofilopoulos1999 ER - TY - JOUR AU - McDevitt, H. AU - Munson, S. AU - Ettinger, R. AU - Wu, A. PY - 2002 DA - 2002// TI - Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity JO - Arthritis Res VL - 4 UR - https://doi.org/10.1186/ar570 DO - 10.1186/ar570 ID - McDevitt2002 ER - TY - JOUR AU - Mageed, R. A. AU - Isenberg, D. A. PY - 2002 DA - 2002// TI - Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production JO - Lupus VL - 11 UR - https://doi.org/10.1191/0961203302lu306rr DO - 10.1191/0961203302lu306rr ID - Mageed2002 ER - TY - JOUR AU - Aringer, M. AU - Smolen, J. S. PY - 2003 DA - 2003// TI - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus JO - Arthritis Res Ther VL - 5 UR - https://doi.org/10.1186/ar770 DO - 10.1186/ar770 ID - Aringer2003 ER - TY - JOUR AU - Suryaprasad, A. G. AU - Prindiville, T. PY - 2003 DA - 2003// TI - The biology of TNF blockade JO - Autoimmun Rev VL - 2 UR - https://doi.org/10.1016/S1568-9972(03)00048-X DO - 10.1016/S1568-9972(03)00048-X ID - Suryaprasad2003 ER - TY - JOUR AU - Kollias, G. PY - 2005 DA - 2005// TI - TNF pathophysiology in murine models of chronic inflammation and autoimmunity JO - Semin Arthritis Rheum VL - 34 UR - https://doi.org/10.1016/j.semarthrit.2005.01.002 DO - 10.1016/j.semarthrit.2005.01.002 ID - Kollias2005 ER - TY - JOUR AU - Coutinho, A. AU - Kazatchkine, M. D. AU - Avrameas, S. PY - 1995 DA - 1995// TI - Natural autoantibodies JO - Curr Opin Immunol VL - 7 UR - https://doi.org/10.1016/0952-7915(95)80053-0 DO - 10.1016/0952-7915(95)80053-0 ID - Coutinho1995 ER - TY - JOUR AU - Schwartz, M. AU - Cohen, I. R. PY - 2000 DA - 2000// TI - Autoimmunity can benefit self-maintenance JO - Immunol Today VL - 21 UR - https://doi.org/10.1016/S0167-5699(00)01633-9 DO - 10.1016/S0167-5699(00)01633-9 ID - Schwartz2000 ER - TY - JOUR AU - Jacob, C. O. AU - McDevitt, H. O. PY - 1988 DA - 1988// TI - Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis JO - Nature VL - 331 UR - https://doi.org/10.1038/331356a0 DO - 10.1038/331356a0 ID - Jacob1988 ER - TY - JOUR AU - Gordon, C. AU - Ranges, G. E. AU - Greenspan, J. S. AU - Wofsy, D. PY - 1989 DA - 1989// TI - Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice JO - Clin Immunol Immunopathol VL - 52 UR - https://doi.org/10.1016/0090-1229(89)90157-8 DO - 10.1016/0090-1229(89)90157-8 ID - Gordon1989 ER - TY - JOUR AU - Gordon, C. AU - Wofsy, D. PY - 1990 DA - 1990// TI - Effects of recombinant murine tumor necrosis factor-alpha on immune function JO - J Immunol VL - 144 ID - Gordon1990 ER - TY - JOUR AU - Kontoyiannis, D. AU - Kollias, G. PY - 2000 DA - 2000// TI - Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor JO - Eur J Immunol VL - 30 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Kontoyiannis2000 ER - TY - JOUR AU - Boswell, J. M. AU - Yui, M. A. AU - Burt, D. W. AU - Kelley, V. E. PY - 1988 DA - 1988// TI - Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis JO - J Immunol VL - 141 ID - Boswell1988 ER - TY - JOUR AU - Yokoyama, H. AU - Kreft, B. AU - Kelley, V. R. PY - 1995 DA - 1995// TI - Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms JO - Kidney Int VL - 47 UR - https://doi.org/10.1038/ki.1995.14 DO - 10.1038/ki.1995.14 ID - Yokoyama1995 ER - TY - JOUR AU - Brennan, D. C. AU - Yui, M. A. AU - Wuthrich, R. P. AU - Kelley, V. E. PY - 1989 DA - 1989// TI - Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury JO - J Immunol VL - 143 ID - Brennan1989 ER - TY - JOUR AU - Edwards, C. K. AU - Zhou, T. AU - Zhang, J. AU - Baker, T. J. AU - De, M. AU - Long, R. E. AU - Borcherding, D. R. AU - Bowlin, T. L. AU - Bluethmann, H. AU - Mountz, J. D. PY - 1996 DA - 1996// TI - Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha JO - J Immunol VL - 157 ID - Edwards1996 ER - TY - JOUR AU - Deguchi, Y. AU - Kishimoto, S. PY - 1991 DA - 1991// TI - Tumour necrosis factor/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice JO - Clin Exp Immunol VL - 85 UR - https://doi.org/10.1111/j.1365-2249.1991.tb05737.x DO - 10.1111/j.1365-2249.1991.tb05737.x ID - Deguchi1991 ER - TY - JOUR AU - Su, X. AU - Zhou, T. AU - Yang, P. AU - Edwards, C. K. AU - Mountz, J. D. PY - 1998 DA - 1998// TI - Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-T DO - 3.0.CO;2-T ID - Su1998 ER - TY - JOUR AU - Segal, R. AU - Dayan, M. AU - Zinger, H. AU - Mozes, E. PY - 2001 DA - 2001// TI - Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline JO - Lupus VL - 10 UR - https://doi.org/10.1191/096120301675275538 DO - 10.1191/096120301675275538 ID - Segal2001 ER - TY - JOUR AU - Charles, P. J. AU - Smeenk, R. J. AU - De Jong, J. AU - Feldmann, M. AU - Maini, R. N. PY - 2000 DA - 2000// TI - Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials JO - Arthritis Rheum VL - 43 UR - https://doi.org/3.0.CO;2-D DO - 3.0.CO;2-D ID - Charles2000 ER - TY - JOUR AU - Kruithof, E. AU - Van Den, B. F. AU - Baeten, D. AU - Herssens, A. AU - De Keyser, F. AU - Mielants, H. AU - Veys, E. M. PY - 2002 DA - 2002// TI - Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up JO - Ann Rheum Dis VL - 61 UR - https://doi.org/10.1136/ard.61.3.207 DO - 10.1136/ard.61.3.207 ID - Kruithof2002 ER - TY - JOUR AU - De Rycke, L. AU - Kruithof, E. AU - Van Damme, N. AU - Hoffman, I. E. AU - Van den, B. N. AU - Van Den, B. F. AU - Veys, E. M. AU - De Keyser, F. PY - 2003 DA - 2003// TI - Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.10876 DO - 10.1002/art.10876 ID - De Rycke2003 ER - TY - JOUR AU - Garcia-Planella, E. AU - Domenech, E. AU - Esteve-Comas, M. AU - Bernal, I. AU - Cabre, E. AU - Boix, J. AU - Gassull, M. A. PY - 2003 DA - 2003// TI - Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab) JO - Eur J Gastroenterol Hepatol VL - 15 UR - https://doi.org/10.1097/00042737-200304000-00003 DO - 10.1097/00042737-200304000-00003 ID - Garcia-Planella2003 ER - TY - JOUR AU - Ferraro-Peyret, C. AU - Coury, F. AU - Tebib, J. G. AU - Bienvenu, J. AU - Fabien, N. PY - 2004 DA - 2004// TI - Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study JO - Arthritis Res Ther VL - 6 UR - https://doi.org/10.1186/ar1440 DO - 10.1186/ar1440 ID - Ferraro-Peyret2004 ER - TY - JOUR AU - Vermeire, S. AU - Noman, M. AU - Van Assche, G. AU - Baert, F. AU - Van Steen, K. AU - Esters, N. AU - Joossens, S. AU - Bossuyt, X. AU - Rutgeerts, P. PY - 2003 DA - 2003// TI - Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study JO - Gastroenterology VL - 125 UR - https://doi.org/10.1016/S0016-5085(03)00701-7 DO - 10.1016/S0016-5085(03)00701-7 ID - Vermeire2003 ER - TY - JOUR AU - Allanore, Y. AU - Sellam, J. AU - Batteux, F. AU - Job, D. C. AU - Weill, B. AU - Kahan, A. PY - 2004 DA - 2004// TI - Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab JO - Clin Exp Rheumatol VL - 22 ID - Allanore2004 ER - TY - JOUR AU - Eriksson, C. AU - Engstrand, S. AU - Sundqvist, K. G. AU - Rantapaa-Dahlqvist, S. PY - 2005 DA - 2005// TI - Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.024182 DO - 10.1136/ard.2004.024182 ID - Eriksson2005 ER - TY - JOUR AU - De Rycke, L. AU - Baeten, D. AU - Kruithof, E. AU - Van Den, B. F. AU - Veys, E. M. AU - De Keyser, F. PY - 2005 DA - 2005// TI - Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21190 DO - 10.1002/art.21190 ID - De Rycke2005 ER - TY - JOUR AU - Sellam, J. AU - Allanore, Y. AU - Batteux, F. AU - Deslandre, C. J. AU - Weill, B. AU - Kahan, A. PY - 2005 DA - 2005// TI - Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate JO - Joint Bone Spine VL - 72 UR - https://doi.org/10.1016/j.jbspin.2004.03.003 DO - 10.1016/j.jbspin.2004.03.003 ID - Sellam2005 ER - TY - JOUR AU - Atzeni, F. AU - Ardizzone, S. AU - Sarzi-Puttini, P. AU - Colombo, E. AU - Maconi, G. AU - De, P. S. AU - Carrabba, M. AU - Bianchi, P. G. PY - 2005 DA - 2005// TI - Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study JO - Aliment Pharmacol Ther VL - 22 UR - https://doi.org/10.1111/j.1365-2036.2005.02576.x DO - 10.1111/j.1365-2036.2005.02576.x ID - Atzeni2005 ER - TY - JOUR AU - Comby, E. AU - Tanaff, P. AU - Mariotte, D. AU - Costentin-Pignol, V. AU - Marcelli, C. AU - Ballet, J. J. PY - 2006 DA - 2006// TI - Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy JO - J Rheumatol VL - 33 ID - Comby2006 ER - TY - JOUR AU - De Bandt, M. AU - Sibilia, J. AU - Le, L. X. AU - Prouzeau, S. AU - Fautrel, B. AU - Marcelli, C. AU - Boucquillard, E. AU - Siame, J. L. AU - Mariette, X. PY - 2005 DA - 2005// TI - Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey JO - Arthritis Res Ther VL - 7 UR - https://doi.org/10.1186/ar1715 DO - 10.1186/ar1715 ID - De Bandt2005 ER - TY - JOUR AU - Ferraccioli, G. F. AU - Assaloni, R. AU - Di Poi, E. AU - Gremese, E. AU - De Marchi, G. AU - Fabris, M. PY - 2002 DA - 2002// TI - Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial JO - Rheumatology (Oxford) VL - 41 UR - https://doi.org/10.1093/rheumatology/41.10.1109 DO - 10.1093/rheumatology/41.10.1109 ID - Ferraccioli2002 ER - TY - JOUR AU - Ferraccioli, G. F. AU - Assaloni, R. AU - Perin, A. PY - 2002 DA - 2002// TI - Drug-induced systemic lupus erythematosus and TNF-alpha blockers JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09798-2 DO - 10.1016/S0140-6736(02)09798-2 ID - Ferraccioli2002 ER - TY - JOUR AU - Colombel, J. F. AU - Loftus, E. V. AU - Tremaine, W. J. AU - Egan, L. J. AU - Harmsen, W. S. AU - Schleck, C. D. AU - Zinsmeister, A. R. AU - Sandborn, W. J. PY - 2004 DA - 2004// TI - The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients JO - Gastroenterology VL - 126 UR - https://doi.org/10.1053/j.gastro.2003.10.047 DO - 10.1053/j.gastro.2003.10.047 ID - Colombel2004 ER - TY - JOUR AU - Ramos-Casals, M. AU - Brito-Zeron, P. AU - Munoz, S. AU - Soria, N. AU - Galiana, D. AU - Bertolaccini, L. AU - Cuadrado, M. J. AU - Khamashta, M. A. PY - 2007 DA - 2007// TI - Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases JO - Medicine (Baltimore) VL - 86 UR - https://doi.org/10.1097/MD.0b013e3181441a68 DO - 10.1097/MD.0b013e3181441a68 ID - Ramos-Casals2007 ER - TY - JOUR AU - Carlson, E. AU - Rothfield, N. PY - 2003 DA - 2003// TI - Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.11033 DO - 10.1002/art.11033 ID - Carlson2003 ER - TY - JOUR AU - Mor, A. AU - Bingham, C. AU - Barisoni, L. AU - Lydon, E. AU - Belmont, H. M. PY - 2005 DA - 2005// TI - Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept JO - J Rheumatol VL - 32 ID - Mor2005 ER - TY - JOUR AU - Stokes, M. B. AU - Foster, K. AU - Markowitz, G. S. AU - Ebrahimi, F. AU - Hines, W. AU - Kaufman, D. AU - Moore, B. AU - Wolde, D. AU - D'Agati, V. D. PY - 2005 DA - 2005// TI - Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis JO - Nephrol Dial Transplant VL - 20 UR - https://doi.org/10.1093/ndt/gfh832 DO - 10.1093/ndt/gfh832 ID - Stokes2005 ER - TY - JOUR AU - Maury, C. P. AU - Teppo, A. M. PY - 1989 DA - 1989// TI - Tumor necrosis factor in the serum of patients with systemic lupus erythematosus JO - Arthritis Rheum VL - 32 UR - https://doi.org/10.1002/anr.1780320206 DO - 10.1002/anr.1780320206 ID - Maury1989 ER - TY - JOUR AU - Studnicka-Benke, A. AU - Steiner, G. AU - Petera, P. AU - Smolen, J. S. PY - 1996 DA - 1996// TI - Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus JO - Br J Rheumatol VL - 35 UR - https://doi.org/10.1093/rheumatology/35.11.1067 DO - 10.1093/rheumatology/35.11.1067 ID - Studnicka-Benke1996 ER - TY - JOUR AU - Gabay, C. AU - Cakir, N. AU - Moral, F. AU - Roux-Lombard, P. AU - Meyer, O. AU - Dayer, J. M. AU - Vischer, T. AU - Yazici, H. AU - Guerne, P. A. PY - 1997 DA - 1997// TI - Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity JO - J Rheumatol VL - 24 ID - Gabay1997 ER - TY - JOUR AU - Davas, E. M. AU - Tsirogianni, A. AU - Kappou, I. AU - Karamitsos, D. AU - Economidou, I. AU - Dantis, P. C. PY - 1999 DA - 1999// TI - Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTN-Falpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus JO - Clin Rheumatol VL - 18 UR - https://doi.org/10.1007/s100670050045 DO - 10.1007/s100670050045 ID - Davas1999 ER - TY - JOUR AU - Aringer, M. AU - Stummvoll, G. H. AU - Steiner, G. AU - Koller, M. AU - Steiner, C. W. AU - Hofler, E. AU - Hiesberger, H. AU - Smolen, J. S. AU - Graninger, W. B. PY - 2001 DA - 2001// TI - Serum interleukin-15 is elevated in systemic lupus erythematosus JO - Rheumatology (Oxford) VL - 40 UR - https://doi.org/10.1093/rheumatology/40.8.876 DO - 10.1093/rheumatology/40.8.876 ID - Aringer2001 ER - TY - JOUR AU - Aderka, D. AU - Wysenbeek, A. AU - Engelmann, H. AU - Cope, A. P. AU - Brennan, F. AU - Molad, Y. AU - Hornik, V. AU - Levo, Y. AU - Maini, R. N. AU - Feldmann, M. PY - 1993 DA - 1993// TI - Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus JO - Arthritis Rheum VL - 36 UR - https://doi.org/10.1002/art.1780360812 DO - 10.1002/art.1780360812 ID - Aderka1993 ER - TY - JOUR AU - Aringer, M. AU - Feierl, E. AU - Steiner, G. AU - Stummvoll, G. H. AU - Höfler, E. AU - Steiner, C. W. AU - Radda, I. AU - Smolen, J. S. AU - Graninger, W. B. PY - 2002 DA - 2002// TI - Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death JO - Lupus VL - 11 UR - https://doi.org/10.1191/0961203302lu160oa DO - 10.1191/0961203302lu160oa ID - Aringer2002 ER - TY - JOUR AU - Takemura, T. AU - Yoshioka, K. AU - Murakami, K. AU - Akano, N. AU - Okada, M. AU - Aya, N. AU - Maki, S. PY - 1994 DA - 1994// TI - Cellular localization of inflammatory cytokines in human glomerulonephritis JO - Virchows Arch VL - 424 UR - https://doi.org/10.1007/BF00191429 DO - 10.1007/BF00191429 ID - Takemura1994 ER - TY - JOUR AU - Malide, D. AU - Russo, P. AU - Bendayan, M. PY - 1995 DA - 1995// TI - Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients JO - Hum Pathol VL - 26 UR - https://doi.org/10.1016/0046-8177(95)90253-8 DO - 10.1016/0046-8177(95)90253-8 ID - Malide1995 ER - TY - JOUR AU - Neale, T. J. AU - Ruger, B. M. AU - Macaulay, H. AU - Dunbar, P. R. AU - Hasan, Q. AU - Bourke, A. AU - Murray-McIntosh, R. P. AU - Kitching, A. R. PY - 1995 DA - 1995// TI - Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy JO - Am J Pathol VL - 146 ID - Neale1995 ER - TY - JOUR AU - Herrera-Esparza, R. AU - Barbosa-Cisneros, O. AU - Villalobos-Hurtado, R. AU - Avalos-Diaz, E. PY - 1998 DA - 1998// TI - Renal expression of IL-6 and TNFalpha genes in lupus nephritis JO - Lupus VL - 7 UR - https://doi.org/10.1191/096120398678919949 DO - 10.1191/096120398678919949 ID - Herrera-Esparza1998 ER - TY - JOUR AU - Aringer, M. AU - McInnes, I. B. AU - Steiner, G. AU - Soleiman, A. AU - Stöckl-Hiesleitner, S. AU - Hoefler, E. AU - Meyer, B. AU - Ulrich, W. AU - Smolen, J. S. PY - 2007 DA - 2007// TI - TNF and interleukin-18 (IL-18) upregulation in kidneys and sera of patients with active systemic lupus erythematosus [abstract] JO - Ann Rheum Dis VL - 66 ID - Aringer2007 ER - TY - JOUR AU - Zampieri, S. AU - Alaibac, M. AU - Iaccarino, L. AU - Rondinone, R. AU - Ghirardello, A. AU - Sarzi-Puttini, P. AU - Peserico, A. AU - Doria, A. PY - 2006 DA - 2006// TI - Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.039362 DO - 10.1136/ard.2005.039362 ID - Zampieri2006 ER - TY - JOUR AU - Smolen, J. S. AU - Strand, V. AU - Cardiel, M. AU - Edworthy, S. AU - Furst, D. AU - Gladman, D. AU - Gordon, C. AU - Isenberg, D. A. AU - Klippel, J. H. AU - Petri, M. PY - 1999 DA - 1999// TI - Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains JO - J Rheumatol VL - 26 ID - Smolen1999 ER - TY - JOUR AU - Elliott, M. J. AU - Maini, R. N. AU - Feldmann, M. AU - Long-Fox, A. AU - Charles, P. AU - Bijl, H. AU - Woody, J. N. PY - 1994 DA - 1994// TI - Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)90632-7 DO - 10.1016/S0140-6736(94)90632-7 ID - Elliott1994 ER - TY - JOUR AU - Brandt, J. AU - Haibel, H. AU - Cornely, D. AU - Golder, W. AU - Gonzalez, J. AU - Reddig, J. AU - Thriene, W. AU - Sieper, J. AU - Braun, J. PY - 2000 DA - 2000// TI - Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab JO - Arthritis Rheum VL - 43 UR - https://doi.org/3.0.CO;2-E DO - 3.0.CO;2-E ID - Brandt2000 ER - TY - JOUR AU - Aringer, M. AU - Graninger, W. B. AU - Steiner, G. AU - Smolen, J. S. PY - 2004 DA - 2004// TI - Safety and efficacy of TNFa blockade in systemic lupus erythematosus – an open label study JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20576 DO - 10.1002/art.20576 ID - Aringer2004 ER - TY - JOUR AU - Gonzalez, C. M. AU - Lopez-Longo, F. J. AU - Monteagudo, I. AU - Vazquez-Coleman, J. AU - Montoro, M. AU - Ortega, C. AU - Nuno, L. AU - Gonzalez-Diaz de Rabago, E. AU - de la Torre-Ortega, I. AU - Carreno, L. PY - 2004 DA - 2004// TI - Anti-TNF agents are effective and safe in the management of systemic lupus erythematosus [abstract] JO - Arthritis Rheum VL - 50 ID - Gonzalez2004 ER - TY - JOUR AU - Micheloud, D. AU - Nuno, L. AU - Rodriguez-Mahou, M. AU - Sanchez-Ramon, S. AU - Ortega, M. C. AU - Aguaron, A. AU - Junco, E. AU - Carbone, J. AU - Fernandez-Cruzl, E. AU - Carreno, L. PY - 2006 DA - 2006// TI - Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy JO - Lupus VL - 15 UR - https://doi.org/10.1177/0961203306070970 DO - 10.1177/0961203306070970 ID - Micheloud2006 ER - TY - JOUR AU - Aringer, M. AU - Houssiau, F. AU - Graninger, W. B. AU - Feierl, E. AU - Steiner, G. AU - Smolen, J. S. PY - 2007 DA - 2007// TI - Long term safety and efficacy of open-label infliximab for SLE [abstract] JO - Ann Rheum Dis VL - 66 ID - Aringer2007 ER - TY - JOUR AU - Hayat, S. J. AU - Uppal, S. S. PY - 2007 DA - 2007// TI - Therapeutic efficacy and safety profile of infliximab in active systemic lupus erythematosus JO - Mod Rheumatol VL - 17 UR - https://doi.org/10.3109/s10165-006-0561-8 DO - 10.3109/s10165-006-0561-8 ID - Hayat2007 ER - TY - JOUR AU - Hayat, S. J. AU - Uppal, S. S. AU - Narayanan Nampoory, M. R. AU - Johny, K. V. AU - Gupta, R. AU - Al-Oun, M. PY - 2007 DA - 2007// TI - Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis JO - Clin Rheumatol VL - 26 UR - https://doi.org/10.1007/s10067-006-0219-0 DO - 10.1007/s10067-006-0219-0 ID - Hayat2007 ER - TY - JOUR AU - Aringer, M. AU - Steiner, G. AU - Graninger, W. B. AU - Hofler, E. AU - Steiner, C. W. AU - Smolen, J. S. PY - 2007 DA - 2007// TI - Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus JO - Arthritis Rheum VL - 56 UR - https://doi.org/10.1002/art.22327 DO - 10.1002/art.22327 ID - Aringer2007 ER - TY - JOUR AU - Katz, R. S. AU - Holt-Daly, N. AU - MacDonald, P. A. PY - 2003 DA - 2003// TI - Frequent infusion reactions associated with infliximab treatment in patients with polyarthritis related to systemic lupus erythematosus [abstract] JO - Arthritis Rheum VL - 48 ID - Katz2003 ER - TY - JOUR AU - Hiepe, F. AU - Bruns, A. AU - Feist, E. AU - Burmester, G. R. PY - 2004 DA - 2004// TI - Successful treatment of a patient suffering from a refractory subacute cutaneous lupus erthematosus (SCLE) with blockers of tumour necrosis factor a [abstract] JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20055 DO - 10.1002/art.20055 ID - Hiepe2004 ER - TY - JOUR AU - Norman, R. AU - Greenberg, R. G. AU - Jackson, J. M. PY - 2006 DA - 2006// TI - Case reports of etanercept in inflammatory dermatoses JO - J Am Acad Dermatol VL - 54 UR - https://doi.org/10.1016/j.jaad.2005.11.1090 DO - 10.1016/j.jaad.2005.11.1090 ID - Norman2006 ER - TY - JOUR AU - Lejeune, F. J. PY - 2002 DA - 2002// TI - Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability JO - J Clin Invest VL - 110 UR - https://doi.org/10.1172/JCI0216493 DO - 10.1172/JCI0216493 ID - Lejeune2002 ER - TY - JOUR AU - Aringer, M. AU - Graninger, W. B. AU - Steiner, G. AU - Smolen, J. S. PY - 2004 DA - 2004// TI - Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20576 DO - 10.1002/art.20576 ID - Aringer2004 ER - TY - JOUR AU - Arbuckle, M. R. AU - McClain, M. T. AU - Rubertone, M. V. AU - Scofield, R. H. AU - Dennis, G. J. AU - James, J. A. AU - Harley, J. B. PY - 2003 DA - 2003// TI - Development of autoantibodies before the clinical onset of systemic lupus erythematosus JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa021933 DO - 10.1056/NEJMoa021933 ID - Arbuckle2003 ER - TY - JOUR AU - Palucka, A. K. AU - Blanck, J. P. AU - Bennett, L. AU - Pascual, V. AU - Banchereau, J. PY - 2005 DA - 2005// TI - Cross-regulation of TNF and IFN-alpha in autoimmune diseases JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0408506102 DO - 10.1073/pnas.0408506102 ID - Palucka2005 ER - TY - JOUR AU - Via, C. S. AU - Shustov, A. AU - Rus, V. AU - Lang, T. AU - Nguyen, P. AU - Finkelman, F. D. PY - 2001 DA - 2001// TI - In vivoneutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL JO - J Immunol VL - 167 UR - https://doi.org/10.4049/jimmunol.167.12.6821 DO - 10.4049/jimmunol.167.12.6821 ID - Via2001 ER - TY - JOUR AU - Pittoni, V. AU - Bombardieri, M. AU - Spinelli, F. R. AU - Scrivo, R. AU - Alessandri, C. AU - Conti, F. AU - Spadaro, A. AU - Valesini, G. PY - 2002 DA - 2002// TI - Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13 JO - Ann Rheum Dis VL - 61 UR - https://doi.org/10.1136/ard.61.8.723 DO - 10.1136/ard.61.8.723 ID - Pittoni2002 ER - TY - JOUR AU - Cope, A. P. AU - Londei, M. AU - Chu, N. R. AU - Cohen, S. B. AU - Elliott, M. J. AU - Brennan, F. M. AU - Maini, R. N. AU - Feldmann, M. PY - 1994 DA - 1994// TI - Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivoby anti-TNF antibodies in patients with rheumatoid arthritis JO - J Clin Invest VL - 94 UR - https://doi.org/10.1172/JCI117394 DO - 10.1172/JCI117394 ID - Cope1994 ER - TY - JOUR AU - Isomaki, P. AU - Panesar, M. AU - Annenkov, A. AU - Clark, J. M. AU - Foxwell, B. M. AU - Chernajovsky, Y. AU - Cope, A. P. PY - 2001 DA - 2001// TI - Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface JO - J Immunol VL - 166 UR - https://doi.org/10.4049/jimmunol.166.9.5495 DO - 10.4049/jimmunol.166.9.5495 ID - Isomaki2001 ER - TY - JOUR AU - Casciola-Rosen, L. AU - Rosen, A. AU - Petri, M. AU - Schlissel, M. PY - 1996 DA - 1996// TI - Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.4.1624 DO - 10.1073/pnas.93.4.1624 ID - Casciola-Rosen1996 ER - TY - JOUR AU - Utz, P. J. AU - Hottelet, M. AU - Schur, P. H. AU - Anderson, P. PY - 1997 DA - 1997// TI - Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus JO - J Exp Med VL - 185 UR - https://doi.org/10.1084/jem.185.5.843 DO - 10.1084/jem.185.5.843 ID - Utz1997 ER - TY - STD TI - ClinicalTrials.gov home page. [http://www.clinicaltrials.gov] UR - http://www.clinicaltrials.gov ID - ref76 ER -